Zydus Animal Health and Investments Limited (ZAHL) a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other ancillary agreements to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.
The deal is expected to be valued around INR 2,921 crores ($396 million approximately) and the acquisition is being undertaken along with a consortium of investors including CPPIB and Rakesh Jhunjhunwala-owned RARE Enterprises.
J Sagar Associates advised
2021-05-01
Deal Value: INR 2921 crores (USD 396 million approx)
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.